Dynamics Special Purpose Corp. Collaboration Agreements
3 Contracts & Agreements
- Collaboration and Option Agreement by and between Senti Biosciences, Inc., and Celest Therapeutics (Shanghai) Co. Ltd., dated November 6, 2023 (Filed With SEC on March 21, 2024)
- Collaboration and Option Agreement by and between BlueRock Therapeutics, LP and Senti Biosciences, Inc., dated May 21, 2021 (Filed With SEC on February 14, 2022)
- Research Collaboration and License Agreement by and between Spark Therapeutics, Inc. and Senti Biosciences, Inc., dated April 9, 2021 (Filed With SEC on February 14, 2022)
